Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Pfizer (PFE) Stock Price & Analysis

36,815 Followers

PFE Stock Chart & Stats

$29.45$0.09(0.31%)
At close: 4:00 PM EST
$26$28$30Aug 17Aug 31Sep 14Sep 28Oct 12Oct 26Nov 9
Day’s Range
$28.95 - $29.50
52-Week Range
$23.62 - $31.44
Previous Close
$29.36
Volume
N/A
Average Volume (3M)
33.99M
Market Cap
$167.35B
Enterprise Value
$190.23B
Total Cash (Recent Filing)
$14.27B
Total Debt (Recent Filing)
$62.67B
Price to Earnings (P/E)
41.7
Beta
0.51
Next Earnings
Feb 02, 2027 (Est.)
EPS Estimate
0.69
Last Dividend Ex-Date
Nov 06, 2026
Dividend Yield
5.84%

Bulls Say, Bears Say

Bulls Say

Non-COVID Product Growth

Growth from non-COVID products and recently launched or acquired medicines indicates Pfizer is rebuilding its commercial base beyond pandemic products. Continued adoption across multiple brands can diversify revenue, support reinvestment, and strengthen the company’s medium-term growth profile.

Strong Cash Generation

Robust operating and free cash flow gives Pfizer capacity to fund research, business development, dividends, and debt obligations internally. Free cash flow also remained strong relative to earnings, supporting financial resilience as the portfolio transitions through upcoming exclusivity pressures.

Pipeline And Cost-Savings Leverage

Large, identified cost savings can provide durable support for margins while Pfizer continues investing in oncology, obesity, vaccines, and immunology programs. A broad late-stage pipeline creates multiple avenues for future product launches and reduces reliance on any single therapeutic area.

Bears Say

Revenue And Margin Compression

The decline in revenue and profitability shows that Pfizer’s post-pandemic normalization has materially reduced current earnings power. Lower margins leave less room to absorb commercial setbacks and make sustained improvement dependent on successful launches, portfolio growth, and continued productivity gains.

Loss-of-Exclusivity Exposure

Upcoming patent and exclusivity losses can create a structural revenue headwind as established products face generic or competitive erosion. The transition may also keep leverage around current levels or modestly higher, limiting flexibility while replacement products and pipeline assets scale.

COVID And Policy Pressure

Declining COVID sales remove a formerly significant revenue contributor, while pricing and reimbursement policy changes could pressure realized prices on other products. Together, these forces increase uncertainty around revenue durability and may constrain margins even as newer medicines grow.

Pfizer News

PFE FAQ

What was Pfizer’s price range in the past 12 months?
Pfizer lowest stock price was $23.62 and its highest was $31.44 in the past 12 months.
What is Pfizer’s market cap?
Pfizer’s market cap is $167.35B.
When is Pfizer’s upcoming earnings report date?
Pfizer’s next earnings report is estimated for Feb 02, 2027 (not yet confirmed), which is in 82 days.
How were Pfizer’s earnings last quarter?
Pfizer released its earnings results on Aug 04, 2026. The company reported $0.77 earnings per share for the quarter, beating the consensus estimate of $0.682 by $0.088.
Is Pfizer overvalued?
According to Wall Street analysts Pfizer’s price is currently Undervalued.
Does Pfizer pay dividends?
Pfizer pays a quarterly dividend of $0.43 which represents an annual dividend yield of 5.84%. See more information on Pfizer dividends here
What is Pfizer’s EPS estimate?
Pfizer’s EPS estimate is 0.69.
How many shares outstanding does Pfizer have?
Pfizer has 5,699,853,500 shares outstanding.
What happened to Pfizer’s price movement after its last earnings report?
Pfizer reported an EPS of $0.77 in its last earnings report, beating expectations of $0.682. Following the earnings report the stock price went up 1.52%.
Which hedge fund is a major shareholder of Pfizer?
Hedge funds hold Pfizer shares: the largest hedge-fund position in Pfizer is 71,886,199 shares, and hedge funds increased their holdings by 32.9M shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology